Company intelligence / Profile preview

Novaestiq

Southlake, Texas, United Statesnovaestiq.com ↗

Ownership: Private
Development stage: Commercial

Overview

Novaestiq has built a broad portfolio of aesthetic and dermatology products since its founding in 2021. Its lead program is the commercialization of saypha MagIQ hyaluronic acid dermal filler, which met primary endpoints in a pivotal trial for nasolabial fold correction. The company also markets or develops innovative devices such as Sebacia AcneIQ for acne and Epilacia for light-based hair removal[3][4]. Clinical results from the saypha MagIQ study showed non-inferiority to Juvederm Ultra XC at 24 weeks with follow-up out to 12 months[4].

Therapeutic areas: Dermatology
Modalities: Hyaluronic acid dermal fillerLight-based device therapySmall molecule (topical skincare)
Industry: Therapeutic Medical Devices

Drug pipeline

3 assets

Sebacia

Commercial

Indications: Acne vulgaris

2 more assets in the full pipeline.

Request access →

Partnerships

Croma Pharma GmbH (development/commercialization partner for HA fillers)

Beyond the preview

Go deeper on Novaestiq.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novaestiq.

Explore the full profile